申请人:Boehringer Ingelheim Pharma KG
公开号:US06319918B1
公开(公告)日:2001-11-20
Substituted indolinones of general formula
having effect on various kinases and cycline/CDK complexes and on the proliferation of various tumour cells. Exemplary compounds are:
3-Z-[1-(4-(N-Benzyl-N-methyl-aminomethyl)-phenylamino)-1-methyl-methylene]-5-amido-2-indolinone and
3-Z-[1-(4-(2,3,4,5-Tetrahydro-benzo(d)azepin-3-yl-methyl)-phenylamino)-1-methyl-methylene]-5-amido-2-indolinone.
通用公式的替代吲哚酮对各种激酶和细胞周期素/CDK复合物以及各种肿瘤细胞的增殖具有影响。示例化合物包括:3-Z-[1-(4-(N-苄基-N-甲基氨甲基)-苯胺基)-1-甲基亚甲基]-5-氨基-2-吲哚酮和3-Z-[1-(4-(2,3,4,5-四氢苯并(d)氮杂环己-3-基甲基)-苯胺基)-1-甲基亚甲基]-5-氨基-2-吲哚酮。